A detailed history of American Capital Advisory, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, American Capital Advisory, LLC holds 2,735 shares of ABBV stock, worth $492,300. This represents 0.31% of its overall portfolio holdings.

Number of Shares
2,735
Previous 2,735 -0.0%
Holding current value
$492,300
Previous $424 Million 27.43%
% of portfolio
0.31%
Previous 0.3%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Apr 09, 2024

BUY
$137.6 - $154.97 $376,336 - $423,842
2,735 New
2,735 $424 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $318B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track American Capital Advisory, LLC Portfolio

Follow American Capital Advisory, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of American Capital Advisory, LLC, based on Form 13F filings with the SEC.

News

Stay updated on American Capital Advisory, LLC with notifications on news.